QA: REGENERX BIOPHARMACEUTICALS INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000707511_2019_REGENERX_BIOPHARMACEUTICALS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000707511')"}

Graph

Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 273,870
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,418
3 remainder_Assets 5,752
4 LiabilitiesCurrent 315,006
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,178,087
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,311,993
9 ResearchAndDevelopmentExpense 81,043
10 remainder_Expenses 0
11 remainder_Revenues 69,667
12 remainder_NetIncome -670,184
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 281,040
1 Liabilities 2,493,093
2 Expenses 1,393,036
3 Revenues 69,667
4 StockholdersEquity -2,212,053
5 NetIncome -1,993,553
6 ComprehensiveNetIncome -1,993,553
7 BaseVar 2,453,510
8 EconomicCapitalRatio -4.18

Edgar->Model Mapping

Feature Distribution

Change over Time